Modena, Italy

Chiara Romagnoli

This inventor holds 1 USPTO granted patent. Top assignees: Università Degli Studi Di Modena E Reggio Emilia, University of California. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chiara Romagnoli. Retrieved from https://idiyas.com/inventor/chiara-romagnoli-uc34yla4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chiara Romagnoli: Innovator in Antibiotic Resistance Solutions

Introduction

Chiara Romagnoli is a prominent inventor based in Modena, Italy. She has made significant contributions to the field of antibiotic resistance, focusing on innovative solutions to combat infections caused by resistant microorganisms. Her work is crucial in the ongoing battle against antibiotic resistance, a growing global health concern.

Latest Patents

Chiara holds 1 patent related to her research on β-lactamase inhibitors. This patent discloses boron-containing compounds and methods for treating infections associated with antibiotic-resistant microorganisms. Her innovative approach aims to provide new avenues for effective treatment options.

Career Highlights

Throughout her career, Chiara has worked with esteemed institutions, including the University of California and the Università Degli Studi Di Modena E Reggio Emilia. Her academic and research endeavors have positioned her as a key figure in the fight against antibiotic resistance.

Collaborations

Chiara has collaborated with notable colleagues, including Oliv Eidam and Emilia Caselli. These partnerships have enhanced her research and contributed to the development of effective solutions in her field.

Conclusion

Chiara Romagnoli's work exemplifies the importance of innovation in addressing critical health challenges. Her contributions to antibiotic resistance research are paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…